Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients

Mayerhoefer, Marius E.; Giraudo, Chiara; Senn, Daniela; More

Clinical Nuclear Medicine . 41(2):101-105, February 2016.

Initial Staging of Locally Advanced Rectal Cancer and Regional Lymph Nodes: Comparison of Diffusion-Weighted MRI With 18F-FDG-PET/CT

Cerny, Milena; Dunet, Vincent; Prior, John Olivier; More

Clinical Nuclear Medicine . 41(4):289-295, April 2016.

FDG PET Performed at Thyroid Remnant Ablation Has a Higher Predictive Value for Long-Term Survival of High-Risk Patients With Well-Differentiated Thyroid Cancer Than Radioiodine...

Gaertner, Florian C.; Okamoto, Shozo; Shiga, Tohru; More

Clinical Nuclear Medicine . 40(5):378-383, May 2015.

First Experience With SPECT/CT Using a 99mTc-Labeled Inhibitor for Prostate-Specific Membrane Antigen in Patients With Biochemical Recurrence of Prostate Cancer

Reinfelder, Julia; Kuwert, Torsten; Beck, Michael; More

Clinical Nuclear Medicine . 42(1):26-33, January 2017.

Etiology of Amyloidosis Determines Myocardial 99mTc-DPD Uptake in Amyloidotic Cardiomyopathy

Longhi, Simone; Bonfiglioli, Rachele; Obici, Laura; More

Clinical Nuclear Medicine . 40(5):446-447, May 2015.

Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Metastatic Differentiated Thyroid Cancers

Masson-Deshayes, Soizic; Schvartz, Claire; Dalban, Cécile; More

Clinical Nuclear Medicine . 40(6):469-475, June 2015.

Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer

Akin-Akintayo, Oladunni O.; Jani, Ashesh B.; Odewole, Oluwaseun; More

Clinical Nuclear Medicine . 42(1):e22-e28, January 2017.